Contributor:

and Sahar Bedrood, MD, PhD

iStent inject in My Practice

Sahar Bedrood, MD, PhD

Advancing Interventional Glaucoma

Sahar Bedrood, MD, PhD

The iStent Infinite®

Sahar Bedrood, MD, PhD; and I. Paul Singh, MD

Interventional Glaucoma

I. Paul Singh, MD; and Sahar Bedrood, MD, PhD

iStent inject: The Glaucoma Surgeon's Perspective

Sahar Bedrood, MD, PhD

Measuring Change in Anterior Lamina Cribrosa Depth

Neda Shamie, MD, Sahar Bedrood, MD, PhD

My Pearls to Successfully Implant XEN Transconjunctivally

Sahar Bedrood, MD, PhD

Tips for Success With a Second-Generation MIGS Device

Arsham Sheybani, MD, Iqbal Ike K. Ahmed, MD, FRCSC, Sahar Bedrood, MD, PhD

Canaloplasty with the iTrack Advance

Sahar Bedrood, MD, PhD

Complex Case Management Pearls

Marjan Farid, MD; and Sahar Bedrood, MD, PhD

iStent Infinite® Live Surgery Broadcast

Iqbal Ike K. Ahmed, MD, FRCSC; I. Paul Singh, MD; and Sahar Bedrood, MD, PhD

iStent Infinite® Surgery

Iqbal Ike K. Ahmed, MD, FRCSC; I. Paul Singh, MD; and Sahar Bedrood, MD, PhD

Innovative Interventional Glaucoma Technologies

Iqbal Ike K. Ahmed, MD, FRCSC; Manjool Shah, MD; Sahar Bedrood, MD, PhD; and Arkadiy Yadgarov, MD

MIGS Developments Anticipated in 2021

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; Sahar Bedrood, MD, PhD; Monisha M. Vora, MD; Michael D. Greenwood, MD; Lorraine M. Provencher, MD; and Larissa Camejo, MD

Positioning Canaloplasty in the Glaucoma Treatment Paradigm

Sahar Bedrood, MD, PhD

Part Two: Important Considerations From GPS Trial Data

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Sahar Bedrood, MD, PhD

Innovations in MIGS: The Impact of Reimbursement Changes

I. Paul Singh, MD; and Sahar Bedrood, MD, PhD

Evolution of the Interventional Glaucoma Mindset

Iqbal Ike K. Ahmed, MD, FRCSC; Manjool Shah, MD; Sahar Bedrood, MD, PhD; and Arkadiy Yadgarov, MD

Outcomes and Highlights of the GPS Trial

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Sahar Bedrood, MD, PhD